379 related items for PubMed ID: 3661766
1. The hypothalamic-pituitary-adrenal system in panic disorder.
Goldstein S, Halbreich U, Asnis G, Endicott J, Alvir J.
Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
[Abstract] [Full Text] [Related]
2. The dexamethasone suppression test in panic disorder and major depressive episodes.
Faludi G, Kaskó M, Perényi A, Arató M, Frecska E.
Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
[Abstract] [Full Text] [Related]
3. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
Avery DH, Osgood TB, Ishiki DM, Wilson LG, Kenny M, Dunner DL.
Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
[Abstract] [Full Text] [Related]
4. Dexamethasone suppression test in patients with panic attacks.
Bridges M, Yeragani VK, Rainey JM, Pohl R.
Biol Psychiatry; 1986 Jul; 21(8-9):853-5. PubMed ID: 3730467
[No Abstract] [Full Text] [Related]
5. Dexamethasone suppression tests in patients with panic disorder.
Lieberman JA, Brenner R, Lesser M, Coccaro E, Borenstein M, Kane JM.
Am J Psychiatry; 1983 Jul; 140(7):917-9. PubMed ID: 6859315
[Abstract] [Full Text] [Related]
6. The dexamethasone suppression test in panic disorder: comparison with normal controls.
Roy-Byrne PP, Bierer LM, Uhde TW.
Biol Psychiatry; 1985 Nov; 20(11):1237-40. PubMed ID: 4052520
[No Abstract] [Full Text] [Related]
7. The dexamethasone suppression test in prepubertal depressed children.
Weller EB, Weller RA, Fristad MA, Preskorn SH, Teare M.
J Clin Psychiatry; 1985 Dec; 46(12):511-3. PubMed ID: 4066616
[Abstract] [Full Text] [Related]
8. Neuroendocrine interrelationships in major depressive disorder.
Targum SD, Sullivan AC, Byrnes SM.
Am J Psychiatry; 1982 Mar; 139(3):282-6. PubMed ID: 6800269
[Abstract] [Full Text] [Related]
9. Major depressive disorder and hypothalamic-pituitary-adrenal axis activity: results from a large cohort study.
Vreeburg SA, Hoogendijk WJ, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Smit JH, Zitman FG, Penninx BW.
Arch Gen Psychiatry; 2009 Jun; 66(6):617-26. PubMed ID: 19487626
[Abstract] [Full Text] [Related]
10. Salivary cortisol levels in persons with and without different anxiety disorders.
Vreeburg SA, Zitman FG, van Pelt J, Derijk RH, Verhagen JC, van Dyck R, Hoogendijk WJ, Smit JH, Penninx BW.
Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
[Abstract] [Full Text] [Related]
11. The significance of HPA axis disturbance in panic disorder.
Coryell W, Noyes R, Schlechte J.
Biol Psychiatry; 1989 Apr 15; 25(8):989-1002. PubMed ID: 2720018
[Abstract] [Full Text] [Related]
12. Hypothalamic-pituitary-adrenal axis activity and age in major depression.
Nelson WH, Orr WW, Shane SR, Stevenson JM.
J Clin Psychiatry; 1984 Mar 15; 45(3):120-1. PubMed ID: 6698943
[Abstract] [Full Text] [Related]
13. Pituitary-adrenal axis rhythm disturbances in psychiatric depression.
Pfohl B, Sherman B, Schlechte J, Stone R.
Arch Gen Psychiatry; 1985 Sep 15; 42(9):897-903. PubMed ID: 2994590
[Abstract] [Full Text] [Related]
14. The combined dexamethasone/corticotropin-releasing hormone stimulation test is more closely associated with features of diurnal activity of the hypothalamo-pituitary-adrenocortical system than the dexamethasone suppression test.
Deuschle M, Schweiger U, Gotthardt U, Weber B, Körner A, Schmider J, Standhardt H, Lammers CH, Krumm B, Heuser I.
Biol Psychiatry; 1998 May 15; 43(10):762-6. PubMed ID: 9606531
[Abstract] [Full Text] [Related]
15. Neuroendocrine aspects of primary endogenous depression. II. Serum dexamethasone concentrations and hypothalamic-pituitary-adrenal cortical activity as determinants of the dexamethasone suppression test response.
Poland RE, Rubin RT, Lesser IM, Lane LA, Hart PJ.
Arch Gen Psychiatry; 1987 Sep 15; 44(9):790-5. PubMed ID: 3632252
[Abstract] [Full Text] [Related]
16. The dexamethasone suppression test in agoraphobia.
Peterson GA, Ballenger JC, Cox DP, Hucek A, Lydiard RB, Laraia MT, Trockman C.
J Clin Psychopharmacol; 1985 Apr 15; 5(2):100-2. PubMed ID: 3988966
[Abstract] [Full Text] [Related]
17. Dexamethasone suppression test in diagnosis of depressive illness.
Hayes PE, Ettigi P.
Clin Pharm; 1983 Apr 15; 2(6):538-45. PubMed ID: 6140096
[Abstract] [Full Text] [Related]
18. Clinical variables and hypothalamic-pituitary-adrenal function in depression. The importance of mood reactivity.
Lemus CZ, Asnis GM, Halbreich U, Harkavy Friedman JM, Van Praag HM, Rubinson E, Eisenberg J.
J Affect Disord; 1987 Apr 15; 12(3):219-21. PubMed ID: 2956306
[Abstract] [Full Text] [Related]
19. Attention-deficit/hyperactivity disorder symptoms and stress-related biomarkers.
Vogel SWN, Bijlenga D, Verduijn J, Bron TI, Beekman ATF, Kooij JJS, Penninx BWJH.
Psychoneuroendocrinology; 2017 May 15; 79():31-39. PubMed ID: 28249186
[Abstract] [Full Text] [Related]
20. Plasma MHPG in depressive disorders and relationship to the dexamethasone suppression test.
Roy A, Jimerson DC, Pickar D.
Am J Psychiatry; 1986 Jul 15; 143(7):846-51. PubMed ID: 3717423
[Abstract] [Full Text] [Related]
Page: [Next] [New Search]
